Literature DB >> 20513541

West Nile virus.

Shannan L Rossi1, Ted M Ross, Jared D Evans.   

Abstract

West Nile virus (WNV) is responsible for thousands of cases of morbidity and mortality in birds, horses, and humans. Epidemics were localized to Europe, Africa, the Middle East, and parts of Asia, and primarily caused a mild febrile illness in humans. In the late 1990s, the virus became more virulent and spread to North America. In humans, the clinical presentation ranges from asymptomatic, seen frequently, to encephalitis/paralysis and death, seen rarely. There is no FDA (Food and Drug Administration)-licensed vaccine for human use, and the only recommended treatment is supportive care. Often, there is a long recovery period. This article reviews the current literature summarizing the molecular virology, epidemiology, clinical manifestations, pathogenesis, diagnosis, treatment, immunology, and protective measures against WNV and WNV infections in humans. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20513541      PMCID: PMC2905782          DOI: 10.1016/j.cll.2009.10.006

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  110 in total

1.  West Nile virus meningoencephalitis: MR imaging findings.

Authors:  Kalliopi A Petropoulou; Steven M Gordon; Richard A Prayson; Paul M Ruggierri
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application.

Authors:  Itzchak Samina; Yevgeny Khinich; Michael Simanov; Mertyn Malkinson
Journal:  Vaccine       Date:  2005-09-30       Impact factor: 3.641

Review 3.  Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis.

Authors:  Kirk M Chan-Tack; Graeme Forrest
Journal:  Scand J Infect Dis       Date:  2005

4.  Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins.

Authors:  Wen Jun Liu; Xiang Ju Wang; Vladislav V Mokhonov; Pei-Yong Shi; Richard Randall; Alexander A Khromykh
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Nucleotide and amino acid changes in West Nile virus strains exhibiting renal tropism in hamsters.

Authors:  Xiaohua Ding; Xiaoyan Wu; Tao Duan; Marina Siirin; Hilda Guzman; Zhanqiu Yang; Robert B Tesh; Shu-Yuan Xiao
Journal:  Am J Trop Med Hyg       Date:  2005-10       Impact factor: 2.345

7.  Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action.

Authors:  Shannan L Rossi; Qizu Zhao; Vivian K O'Donnell; Peter W Mason
Journal:  Virology       Date:  2005-01-20       Impact factor: 3.616

8.  Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis.

Authors:  Robyn S Klein; Eugene Lin; Bo Zhang; Andrew D Luster; Judy Tollett; Melanie A Samuel; Michael Engle; Michael S Diamond
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells.

Authors:  Justin Jang-Hann Chu; Mah-Lee Ng
Journal:  J Biol Chem       Date:  2004-10-07       Impact factor: 5.157

Review 10.  Virology, pathology, and clinical manifestations of West Nile virus disease.

Authors:  Edward B Hayes; James J Sejvar; Sherif R Zaki; Robert S Lanciotti; Amy V Bode; Grant L Campbell
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

View more
  50 in total

Review 1.  Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.

Authors:  Gavin C Bowick; Alexander J McAuley
Journal:  Bioeng Bugs       Date:  2011-05-01

2.  MicroRNA reduction of neuronal West Nile virus replication attenuates and affords a protective immune response in mice.

Authors:  Terza Brostoff; Patricia A Pesavento; Christopher M Barker; Joan L Kenney; Elizabeth A Dietrich; Nisha K Duggal; Angela M Bosco-Lauth; Aaron C Brault
Journal:  Vaccine       Date:  2016-09-13       Impact factor: 3.641

Review 3.  West Nile virus: A re-emerging pathogen revisited.

Authors:  Miguel A Martín-Acebes; Juan-Carlos Saiz
Journal:  World J Virol       Date:  2012-04-12

4.  Ecological niche modelling of potential West Nile virus vector mosquito species and their geographical association with equine epizootics in Italy.

Authors:  Lapo Mughini-Gras; Paolo Mulatti; Francesco Severini; Daniela Boccolini; Roberto Romi; Gioia Bongiorno; Cristina Khoury; Riccardo Bianchi; Fabrizio Montarsi; Tommaso Patregnani; Lebana Bonfanti; Giovanni Rezza; Gioia Capelli; Luca Busani
Journal:  Ecohealth       Date:  2013-10-12       Impact factor: 3.184

5.  Vector competence of Culex neavei and Culex quinquefasciatus (Diptera: Culicidae) from Senegal for lineages 1, 2, Koutango and a putative new lineage of West Nile virus.

Authors:  Gamou Fall; Mawlouth Diallo; Cheikh Loucoubar; Ousmane Faye; Amadou Alpha Sall
Journal:  Am J Trop Med Hyg       Date:  2014-02-24       Impact factor: 2.345

Review 6.  From dengue to Zika: the wide spread of mosquito-borne arboviruses.

Authors:  Shivani Sukhralia; Mansi Verma; Shruthi Gopirajan; P S Dhanaraj; Rup Lal; Neeti Mehla; Chhaya Ravi Kant
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-28       Impact factor: 3.267

Review 7.  West Nile virus state of the art report of MALWEST Project.

Authors:  Andriani Marka; Alexandros Diamantidis; Anna Papa; George Valiakos; Serafeim C Chaintoutis; Dimitrios Doukas; Persefoni Tserkezou; Alexios Giannakopoulos; Konstantinos Papaspyropoulos; Eleni Patsoula; Evangelos Badieritakis; Agoritsa Baka; Maria Tseroni; Danai Pervanidou; Nikos T Papadopoulos; George Koliopoulos; Dimitrios Tontis; Chrysostomos I Dovas; Charalambos Billinis; Athanassios Tsakris; Jenny Kremastinou; Christos Hadjichristodoulou; Nikolaos Vakalis; Evdokia Vassalou; Spyridoula Zarzani; Athanassios Zounos; Katerina Komata; Georgios Balatsos; Stavroula Beleri; Anastasia Mpimpa; Vasilios Papavasilopoulos; Ioannis Rodis; Grigorios Spanakos; Nikolaos Tegos; Vasiliki Spyrou; Zisis Dalabiras; Periklis Birtsas; Labrini Athanasiou; Maria Papanastassopoulou; Charalambos Ioannou; Christos Athanasiou; Christos Gerofotis; Elpida Papadopoulou; Theodolinta Testa; Ourania Tsakalidou; George Rachiotis; Nikolaos Bitsolas; Zissis Mamouris; Katerina Moutou; Theologia Sarafidou; Konstantinos Stamatis; Konstantina Sarri; Sotirios Tsiodras; Theano Georgakopoulou; Marios Detsis; Maria Mavrouli; Anastasia Stavropoulou; Lida Politi; Georgia Mageira; Varvara Christopoulou; Georgia Diamantopoulou; Nikolaos Spanakis; Georgia Vrioni; Evangelia-Theofano Piperaki; Kornilia Mitsopoulou; Ilias Kioulos; Antonios Michaelakis; Ioannis Stathis; Ioannis Tselentis; Anna Psaroulaki; Maria Keramarou; Dimosthenis Chochlakis; Yeorgios Photis; Maria Konstantinou; Panagiotis Manetos; Stylianos Tsobanoglou; Spyros Mourelatos; Vasilis Antalis; Panagiotis Pergantas; Georgios Eleftheriou
Journal:  Int J Environ Res Public Health       Date:  2013-12-02       Impact factor: 3.390

Review 8.  Zika Virus.

Authors:  Didier Musso; Duane J Gubler
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

9.  NS1' colocalizes with NS1 and can substitute for NS1 in West Nile virus replication.

Authors:  Lucy B Young; Ezequiel Balmori Melian; Alexander A Khromykh
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

10.  Structural and Functional Characterization of Programmed Ribosomal Frameshift Signals in West Nile Virus Strains Reveals High Structural Plasticity Among cis-Acting RNA Elements.

Authors:  Christine Moomau; Sharmishtha Musalgaonkar; Yousuf A Khan; John E Jones; Jonathan D Dinman
Journal:  J Biol Chem       Date:  2016-05-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.